| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-100 |
Sentence |
denotes |
AGE-induced neuronal cell death is enhanced in G2019S LRRK2 mutation with increased RAGE expression. |
| T1 |
0-100 |
Sentence |
denotes |
AGE-induced neuronal cell death is enhanced in G2019S LRRK2 mutation with increased RAGE expression. |
| T2 |
101-112 |
Sentence |
denotes |
Background: |
| T2 |
101-112 |
Sentence |
denotes |
Background: |
| T3 |
113-250 |
Sentence |
denotes |
Leucine-rich repeat kinase 2 (LRRK2) mutations represent the most common genetic cause of sporadic and familial Parkinson's disease (PD). |
| T3 |
113-250 |
Sentence |
denotes |
Leucine-rich repeat kinase 2 (LRRK2) mutations represent the most common genetic cause of sporadic and familial Parkinson's disease (PD). |
| T4 |
251-371 |
Sentence |
denotes |
Especially, LRRK2 G2019S missense mutation has been identified as the most prevalent genetic cause in the late-onset PD. |
| T4 |
251-371 |
Sentence |
denotes |
Especially, LRRK2 G2019S missense mutation has been identified as the most prevalent genetic cause in the late-onset PD. |
| T5 |
372-561 |
Sentence |
denotes |
Advanced glycation end products (AGEs) are produced in high amounts in diabetes and diverse aging-related disorders, such as cardiovascular disease, renal disease, and neurological disease. |
| T5 |
372-561 |
Sentence |
denotes |
Advanced glycation end products (AGEs) are produced in high amounts in diabetes and diverse aging-related disorders, such as cardiovascular disease, renal disease, and neurological disease. |
| T6 |
562-679 |
Sentence |
denotes |
AGEs trigger intracellular signaling pathway associated with oxidative stress and inflammation as well as cell death. |
| T6 |
562-679 |
Sentence |
denotes |
AGEs trigger intracellular signaling pathway associated with oxidative stress and inflammation as well as cell death. |
| T7 |
680-780 |
Sentence |
denotes |
RAGE, receptor of AGEs, is activated by interaction with AGEs and mediates AGE-induced cytotoxicity. |
| T7 |
680-780 |
Sentence |
denotes |
RAGE, receptor of AGEs, is activated by interaction with AGEs and mediates AGE-induced cytotoxicity. |
| T8 |
781-862 |
Sentence |
denotes |
Whether AGE and RAGE are involved in the pathogenesis of mutant LRRK2 is unknown. |
| T8 |
781-862 |
Sentence |
denotes |
Whether AGE and RAGE are involved in the pathogenesis of mutant LRRK2 is unknown. |
| T9 |
863-871 |
Sentence |
denotes |
Methods: |
| T9 |
863-871 |
Sentence |
denotes |
Methods: |
| T10 |
872-1120 |
Sentence |
denotes |
Using cell lines transfected with mutant LRRK2 as well as primary neuronal cultures derived from LRRK2 wild-type (WT) and G2019S transgenic mice, we compared the impact of AGE treatment on the survival of control and mutant cells by immunostaining. |
| T10 |
872-1120 |
Sentence |
denotes |
Using cell lines transfected with mutant LRRK2 as well as primary neuronal cultures derived from LRRK2 wild-type (WT) and G2019S transgenic mice, we compared the impact of AGE treatment on the survival of control and mutant cells by immunostaining. |
| T11 |
1121-1232 |
Sentence |
denotes |
We also examined the levels of RAGE proteins in the brains of transgenic mice and PD patients by western blots. |
| T11 |
1121-1232 |
Sentence |
denotes |
We also examined the levels of RAGE proteins in the brains of transgenic mice and PD patients by western blots. |
| T12 |
1233-1241 |
Sentence |
denotes |
Results: |
| T12 |
1233-1241 |
Sentence |
denotes |
Results: |
| T13 |
1242-1361 |
Sentence |
denotes |
We show that LRRK2 G2019S mutant-expressing neurons were more sensitive to AGE-induced cell death compared to controls. |
| T13 |
1242-1361 |
Sentence |
denotes |
We show that LRRK2 G2019S mutant-expressing neurons were more sensitive to AGE-induced cell death compared to controls. |
| T14 |
1362-1463 |
Sentence |
denotes |
Furthermore, we found that the levels of RAGE proteins were upregulated in LRRK2 G2019S mutant cells. |
| T14 |
1362-1463 |
Sentence |
denotes |
Furthermore, we found that the levels of RAGE proteins were upregulated in LRRK2 G2019S mutant cells. |
| T15 |
1464-1476 |
Sentence |
denotes |
Conclusions: |
| T15 |
1464-1476 |
Sentence |
denotes |
Conclusions: |
| T16 |
1477-1609 |
Sentence |
denotes |
These data suggest that enhanced AGE-RAGE interaction contributes to LRRK2 G2019S mutation-mediated progressive neuronal loss in PD. |
| T16 |
1477-1609 |
Sentence |
denotes |
These data suggest that enhanced AGE-RAGE interaction contributes to LRRK2 G2019S mutation-mediated progressive neuronal loss in PD. |